| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52685-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47741-0.1mg | |||
| IHC-Prediluted | NBP2-48203 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34553-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22170-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22123-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22053-50ul | |||
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M138) [NBP3-23233] - Immunocytochemical labeling of activated p38 MAPK in pervanadate-treated mouse C2C12. The cells were labeled with mouse monoclonal p38 alpha MAPK and p38 MAPK (T180/Y182) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.](http://images.novusbio.com/fullsize/nbp3-23233_mouse-p38-alpha-mab-m138-19920231410114.jpg "Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M138) [NBP3-23233] - Immunocytochemical labeling of activated p38 MAPK in pervanadate-treated mouse C2C12. The cells were labeled with mouse monoclonal p38 alpha MAPK and p38 MAPK (T180/Y182) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.")
![Western Blot: p38 alpha Antibody (M138) [NBP3-23233] - Western blot analysis of A431 cells serum starved overnight (lanes 1 & 3) or treated with pervanadate (1 mM) for 30 minutes (lanes 2 & 4). The blot was probed with anti-p38 alpha (lanes 1 & 2) or anti-p38 (T180/Y182) (lanes 3-4). Lanes 5-7 shows a blot of A431 cells treated with pervanadate and probed with anti-p38 (T180/Y182) in the presence of no peptide (lane 5), phospho-ERK1 (T202/Y204) peptide (lane 6) or phospho-p38 (T180/Y182) peptide (lane 7).](http://images.novusbio.com/fullsize/nbp3-23233_mouse-p38-alpha-mab-m138-19920231252360.jpg)
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-199202318202923.jpg "Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: p38 alpha Antibody (M548) [NBP3-23234] - Western blot analysis of human A431 cells (lanes 1 & 2) and rat A7r5 cells (lanes 3 & 4). The blot was probed with mouse monoclonal anti-p38 alpha (C-terminal) clone M548 at a dilution of 1:250 (lanes 1 & 3) or 1:1000 (lanes 2 & 4).](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-19920231856916.jpg)
![Flow Cytometry: EGFR Antibody (Matuzumab) - Chimeric [NBP2-52685] - Flow-cytometry using the anti-EGFR antibody Matuzumab. HeLa (A) and A431 (B) cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of Matuzumab (NBP2-52685, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using an anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/EGFR-Antibody-Matuzumab-Chimeric-Flow-Cytometry-NBP2-52685-img0002.jpg "Flow Cytometry: EGFR Antibody (Matuzumab) - Chimeric [NBP2-52685] - Flow-cytometry using the anti-EGFR antibody Matuzumab. HeLa (A) and A431 (B) cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of Matuzumab (NBP2-52685, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using an anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.")
![Immunocytochemistry /Immunofluorescence: EGFR Antibody (Matuzumab) - Chimeric - Azide and BSA Free [NBP2-52685] - Immunofluorescence staining of fixed A431 cells with anti-EGFR antibody Matuzumab. Immunofluorescence analysis of unpermeabilisd paraformaldehyde fixed A431 cells on Shi-fix coverslips stained with NBP2-52685 at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-52685, DAPI, merged channels and an isotype control. The isotype control was stained with unimmunised rabbit IgG followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp2-52685_rabbit-monoclonal-egfr-antibody-matuzumab-chimeric-74202522141213.png)
![Western Blot: DIAPH-2 Antibody [NB600-280] - Samples: Whole cell lysate from 293T (15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded), HeLa (H; 50 ug) and Jurkat (J; 50 ug) cells. Antibodies: Affinity purified rabbit anti-Diaphanous 2 antibody.](http://images.novusbio.com/fullsize/DIAPH-2-Antibody-Western-Blot-NB600-280-img0004.jpg "Western Blot: DIAPH-2 Antibody [NB600-280] - Samples: Whole cell lysate from 293T (15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded), HeLa (H; 50 ug) and Jurkat (J; 50 ug) cells. Antibodies: Affinity purified rabbit anti-Diaphanous 2 antibody.")
![Western Blot: DIAPH-2 Antibody [NB600-280] - Whole cell lysate (50 ug) from HEK 293T cells. Antibody used at the indicated concentrations.](http://images.novusbio.com/fullsize/DIAPH-2-Antibody-Western-Blot-NB600-280-img0002.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (SPM622) [NBP2-45149] - Human Placenta stained with EGFR Monoclonal Antibody (SPM622).](http://images.novusbio.com/fullsize/EGFR-Antibody-SPM622-Immunohistochemistry-Paraffin-NBP2-45149-img0001.jpg "Immunohistochemistry-Paraffin: EGFR Antibody (SPM622) [NBP2-45149] - Human Placenta stained with EGFR Monoclonal Antibody (SPM622).")
![Western Blot: NCK2 Antibody (S01-3C6) [NBP3-15063] - Western blot detection of NCK2 in K562, Rat Brain, C6, 3T3, Hela cell lysates using NCK2 Rabbit mAb (1:1000 diluted). Predicted band size: 43kDa. Observed band size: 43kDa.](http://images.novusbio.com/fullsize/NCK2-Antibody-S01-3C6-Western-Blot-NBP3-15063-img0001.jpg "Western Blot: NCK2 Antibody (S01-3C6) [NBP3-15063] - Western blot detection of NCK2 in K562, Rat Brain, C6, 3T3, Hela cell lysates using NCK2 Rabbit mAb (1:1000 diluted). Predicted band size: 43kDa. Observed band size: 43kDa.")
![Immunocytochemistry/Immunofluorescence: NCK2 Antibody (S01-3C6) [NBP3-15063] - Immunofluorescence of NCK2 (green) in Hela cells using NBP3-15063 at dilution 1/200, and DAPI (blue)](http://images.novusbio.com/fullsize/nbp3-15063_rabbit-nck2-mab-s01-3c6-113202515145440.jpg)
![Western Blot: BCAT1 Antibody - BSA Free [NBP3-47874] - Human kidney tissue were subjected to SDS PAGE followed by western blot with (BCAT1 antibody) at dilution of 1:300](http://images.novusbio.com/fullsize/nbp3-47874_rabbit-bcat1-pab-bsa-free-284202511352292.jpg "Western Blot: BCAT1 Antibody - BSA Free [NBP3-47874] - Human kidney tissue were subjected to SDS PAGE followed by western blot with (BCAT1 antibody) at dilution of 1:300")
![Immunohistochemistry: BCAT1 Antibody - BSA Free [NBP3-47874] - Immunohistochemistry of paraffin-embedded human lymphoma tissue slide using (BCAT1 Antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-47874_rabbit-bcat1-pab-bsa-free-284202511425574.jpg)
![Western Blot: Granulin Antibody (SR1971) [NBP3-22170] - Western blot analysis using NBP3-22170 in 293T cell lysate.](http://images.novusbio.com/fullsize/nbp3-22170_rabbit-granulin-mab-sr1971-572023152465.jpg "Western Blot: Granulin Antibody (SR1971) [NBP3-22170] - Western blot analysis using NBP3-22170 in 293T cell lysate.")
![Western Blot: Calpain S1 Antibody (SR1462) [NBP3-22123] - Western blot analysis using NBP3-22123 in T47D cell lysate.](http://images.novusbio.com/fullsize/nbp3-22123_rabbit-calpain-s1-mab-sr1462-57202316494288.jpg "Western Blot: Calpain S1 Antibody (SR1462) [NBP3-22123] - Western blot analysis using NBP3-22123 in T47D cell lysate.")
![Western Blot: PCNP Antibody - BSA Free [NBP3-47200] - HepG2 cells were subjected to SDS PAGE followed by western blot with (PCNP antibody) at dilution of 1:600](http://images.novusbio.com/fullsize/nbp3-47200_rabbit-pcnp-pab-bsa-free-284202512343822.jpg "Western Blot: PCNP Antibody - BSA Free [NBP3-47200] - HepG2 cells were subjected to SDS PAGE followed by western blot with (PCNP antibody) at dilution of 1:600")
![Immunohistochemistry: PCNP Antibody - BSA Free [NBP3-47200] - Immunohistochemistry of paraffin-embedded human lymphoma using (PCNP antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-47200_rabbit-pcnp-pab-bsa-free-284202512313645.jpg)
![Western Blot: Calpain S1 Antibody (SR1446) [NBP3-22053] - Western blot analysis using NBP3-22053 in 293T cell lysate.](http://images.novusbio.com/fullsize/nbp3-22053_rabbit-calpain-s1-mab-sr1446-57202316112186.jpg "Western Blot: Calpain S1 Antibody (SR1446) [NBP3-22053] - Western blot analysis using NBP3-22053 in 293T cell lysate.")